跳至主要内容
临床试验/NCT05819931
NCT05819931招募中不适用

Evaluation of the Effect of Respiratory Physiotherapy by Mechanical In-exsufflator on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study

University Hospital, Toulouse2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年8月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
36
试验地点
2
主要终点
cough peak expiratory flow evolution

研究概览

简要总结

The study aims to evaluate the effect of mechanical insufflator-exsufflator on the respiratory functions of Amyotrophic Lateral Sclerosis (ALS) patients evaluated via peak expiratory flow on cough (PEFC) measurements. The evolution of their PEFC is monitored to see if the curative management can have a positive impact on the latter.

详细描述

Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative pathology without curative treatment at present, the outcome is fatal after 3 to 5 years of evolution on average. The disease results in progressive paralysis of the muscles involved in voluntary motricity (progressive and intricate impairment of locomotor, phonation and swallowing capacities as well as ventilatory function). In France, the management of ALS is based on a diversified multidisciplinary follow-up (physiotherapy, speech therapy, occupational therapy, neuropsychology) in the ALS Reference Center in conjunction with the city care networks. It is centered on the evaluation, and the early compensation of the various symptoms, especially the respiratory problems.

Thus, this study aims to evaluate the effect of mechanical insufflator-exsufflator on the respiratory functions of these patients, evaluated via cough peak expiratory flow measurements (CPEF).

The study is conducted in collaboration with the physiotherapists of each patient enrolled, to evaluate the respiratory function by peak expiratory flow on cough (PEFC) after 4 weeks of treatment with Mechanical In-Exsufflator (MIE) (3 weekly sessions for two weeks, then one daily session for 2 weeks) in ALS patients presenting with a poorly effective cough (PEFC between 160 and 255 L/min) and having an indication of punctual MIE.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed ALS categorized as probable or certain according to the revised Awaji-Shima criteria [27].
  • ALS of spinal, bulbar or respiratory forms
  • Peak Flow measure between 160 and 255 L/min (recommendation of MIE in case of congestion, with the possibility of daily sessions)
  • Patient who has not benefited from treatment by MIE in the past year (less than 10 sessions in total)
  • Patient able to use the MIE and perform the collection, or having a caregiver able to help
  • Patient receiving physiotherapist treatment greater than or equal to twice a week

排除标准

  • Psychiatric (DSM-5) or cognitive disorders incompatible with participation in the study
  • Contraindication to the use of an MIE (pneumothorax for example)
  • Insufficient level in French for understanding the study and completing the questionnaires
  • Current or past participation in another innovative research or care program relating to respiratory functions
  • Emergency situation for which the MIE must be set up within less than a week
  • Exclusion during the study :
  • Appearance of a serious contraindication to the practice of MIE during the study (for example rib fracture during a fall)
  • Patient's physiotherapist refusing to do the study

研究组 & 干预措施

Mechanical In-Exsufflator treatment

Experimental

干预措施: Mechanical In-Exsufflator treatment (Device)

结局指标

主要结局

cough peak expiratory flow evolution

时间窗: 4 weeks post treatment initiation

evolution of respiratory function by peak expiratory flow on cough (PEFC) after 4 weeks of treatment with Mechanical In-Exsufflator (3 weekly sessions for two weeks then one daily session for 2 weeks) in ALS patients presenting with a poorly effective cough (Cough Peak Expiratory Flow between 160 and 255) and having an indication of punctual MIE. Ratio between the PEFC 4 weeks post treatment initiation and PEFC at baseline can show decrease in respiratory function if \<1 ; increase in respiratory functions if \>1 and a conservation of respiratory function if = 1. A PEFC remaining within 10% of its initial value (rounded to the nearest ten) is considered unmodified

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验